1,6-Dihydro-2H-indeno[5,4-b]furan Derivatives: Design, Synthesis, and Pharmacological Characterization of a Novel Class of Highly Potent MT2-Selective Agonists

被引:43
作者
Koike, Tatsuki [1 ]
Hoashi, Yasutaka [1 ]
Takai, Takafumi [1 ]
Nakayama, Masaharu [1 ]
Yukuhiro, Nobuhito [1 ]
Ishikawa, Takashi [1 ]
Hirai, Keisuke [1 ]
Uchikawa, Osamu [1 ]
机构
[1] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Yodogawa Ku, Osaka 5328686, Japan
关键词
MELATONIN RECEPTOR AGONISTS; RAMELTEON TAK-375; CIRCADIAN-RHYTHMS; SLEEP; ANTAGONISTS; SUBTYPES; SERIES;
D O I
10.1021/jm200221q
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of 1,6-dihydro-2H-indeno[5,4-b]furan derivatives were designed and synthesized as MT2-selective ligands. This scaffold was identified as a potent mimic of the 5-methoxy indole core of melatonin, and introduction of a cyclohexylmethyl group at the 7-position of this scaffold afforded an MT2-selective ligand 15 (K-i = 0.012 nM) with high MT1/MT2 selectivity (799). Compound 15 was identified as a potent full agonist for the MT2 subtype and exhibited reentrainment effects to a new light/dark cycle in ICR mice at 3-30 mg/kg. This result demonstrated the involvement of the MT2 receptors in chronobiotic activity.
引用
收藏
页码:3436 / 3444
页数:9
相关论文
共 32 条
[1]  
ARENDT J, 1991, ADV PINEAL, V5, P299
[2]  
Blask David E., 2002, Current Topics in Medicinal Chemistry, V2, P113, DOI 10.2174/1568026023394407
[3]  
Dubocovich M.L., 2000, IUPHAR COMPENDIUM RE, V2nd, P271
[4]   Functional MT1 and MT2 melatonin receptors in mammals [J].
Dubocovich, ML ;
Markowska, M .
ENDOCRINE, 2005, 27 (02) :101-110
[5]   Melatonin receptor antagonists that differentiate between the human Mel(1a), and Mel(1b) recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML(1) presynaptic heteroreceptor [J].
Dubocovich, ML ;
Masana, MI ;
Iacob, S ;
Sauri, DM .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (03) :365-375
[6]   Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms [J].
Dubocovich, ML ;
Yun, K ;
Al-Ghoul, WM ;
Benloucif, S ;
Masana, MI .
FASEB JOURNAL, 1998, 12 (12) :1211-1220
[7]   4-Substituted anilides as selective melatonin MT2 receptor agonists [J].
Epperson, JR ;
Deskus, JA ;
Gentile, AJ ;
Iben, LG ;
Ryan, E ;
Sarbin, NS .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (04) :1023-1026
[8]   Synthesis of a novel series of benzocycloalkene derivatives as melatonin receptor agonists [J].
Fukatsu, K ;
Uchikawa, O ;
Kawada, M ;
Yamano, T ;
Yamashita, M ;
Kato, K ;
Hirai, K ;
Hinuma, S ;
Miyamoto, M ;
Ohkawa, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (19) :4212-4221
[9]   Synthesis of compounds as melatonin Agonists and antagonists [J].
Garratt, Peter J. ;
Tsotinis, Andrew .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (10) :1075-1088
[10]   Investigational melatonin receptor agonists [J].
Hardeland, Ruediger .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (06) :747-764